Category: Health

• Two new reduced nicotine cigarettes can now be sold in the United States, but experts are mixed about their benefits.
• The FDA hopes these products will help adult smokers cut back on how many cigarettes they smoke.
• It remains to be seen if smokers, given a choice, will opt for less nicotine.

The Food and Drug Administration (FDA)Trusted Source on Tuesday authorized the sale of two new reduced nicotine cigarettes.

Moonlight and Moonlight Menthol, manufactured by 22nd Century Group Inc., are filtered combustible cigarettes that contain less nicotine than typical commercial cigarettes.

The FDA hopes these products will help adult smokers cut back on how many cigarettes they smoke each day.

“Today’s authorization represents the first product to successfully demonstrate the potential for these types of tobacco products to help reduce nicotine dependence among addicted smokers,” said Mitch ZellerTrusted Source, JD, director of the FDA’s Center for Tobacco Products, in a news releaseTrusted Source Tuesday.

Less nicotine but still toxic

Nicotine is highly addictive. A 2016 study found that smokers try to quit on average 30 times or more before they’re able stop for 1 year or longer.

Although many tools are available to help smokers quit, lowering the nicotine level is seen as another option.

Reduced nicotine cigarettes have been on the market for decades, but the two new cigarettes have an even lower nicotine content: 0.2 to 0.7 milligramsTrusted Source per cigarette. Conventional cigarettes contain 10 to 14 milligrams nicotine per cigarette.

Before approval, the FDA carried out a “rigorous science-based review” of 22nd Century Group’s applications for these products. But the agency said this doesn’t mean they’re safe or FDA approved.

“Consumers should be aware that this is not a safer cigarette in terms of cancer risks or lung health,” said Lynn T. Kozlowski, PhD, a professor of community health and health behavior at the University at Buffalo.

“Reduced nicotine cigarettes are tobacco cigarettes that reduce or eliminate nicotine-based effects of smoking,” Kozlowski said, “but otherwise they are tobacco cigarettes that are as toxic as regular tobacco cigarettes.”

This is something many people aren’t aware of.

A 2018 study found that almost half of smokers incorrectly believed that very low nicotine cigarettes were less likely to cause cancer than typical cigarettes. People who thought this also said they’d be less likely to quit.

Lower nicotine may help people quit

Research suggests that lowering the amount of nicotine in cigarettes may help people make a clean break.

A 2015 clinical trial found that people who smoked reduced nicotine cigarettes were less dependent on cigarettes. As a result, they smoked fewer cigarettes and made more attempts to quit, compared to people who smoked conventional cigarettes.

Another study found young adults reported that reduced nicotine cigarettes were less satisfying. They also ended up smoking fewer cigarettes per day.

It’s not clear if youth who experiment with reduced nicotine cigarettes are less likely to develop a dependence on them. Research in rats, though, suggests that may be the case.

Moe Gelbart, PhD, a California-based psychologist with Torrance Memorial Medical Center who specializes in addiction, is concerned that people may end up smoking more reduced nicotine cigarettes just to keep their nicotine intake at the level they’re used to.

This would also increase the amount of carcinogens and toxinsTrusted Source they’re exposed to.

He’s also concerned that reduced nicotine cigarettes may just become another way to entice new users to start smoking.

The FDA said in the release it will continue to monitor the new products to ensure there’s not “a notable increase in the number of non-smokers, including youth, using [them].”

As with other tobacco research, though, it could be years before the full impact of reduced nicotine cigarettes is known — a pattern we’ve seen before.

“When vaping came out, e-cigarettes were supposed to help people reduce their dependence on nicotine,” Gelbart said. “Now 10 or 15 years later, we’re finding out the horrors of that industry.”

Push for reduced nicotine in cigarettes

Given the existing research on reduced nicotine cigarettes, in 2015 the World Health OrganizationTrusted Source called for the sale of cigarettes to be limited to those with low nicotine levels.

The FDA also announced in July 2017Trusted Source a plan to reduce nicotine levels in all cigarettes to nonaddictive levels. However, as of last month, the FDA’s plan appears to have stalled.

This leaves the Moonlight and Moonlight Menthol reduced nicotine cigarettes competing against a crowded field of cigarettes with higher nicotine levels.

It remains to be seen if smokers, given a choice, will opt for less nicotine.

Kozlowski says similar reduced nicotine cigarettes that were on the market several years ago weren’t a commercial success, even though they were heavily marketed.

“Time will tell the extent to which [the new products] might help some smokers quit smoking,” Kozlowski said, “but for that to be a win for health, they will need to also stop using the reduced nicotine cigarettes at some point.”

Gelbart says if someone really wants to overcome their nicotine addiction, their goal should be abstinence.

“There are numerous evidence-based treatment methods for stopping nicotine use,” Gelbart said. “If people really want to stop, that’s the way to go — not by reducing the amount of nicotine in the cigarettes they smoke.”

Findings do not link similar contact with cats to either schizophrenia or bipolar disorder

Ever since humans domesticated the dog, the faithful, obedient and protective animal has provided its owner with companionship and emotional well-being. Now, a study from Johns Hopkins Medicine suggests that being around “man’s best friend” from an early age may have a health benefit as well — lessening the chance of developing schizophrenia as an adult.

And while Fido may help prevent that condition, the jury is still out on whether or not there’s any link, positive or negative, between being raised with Fluffy the cat and later developing either schizophrenia or bipolar disorder.

“Serious psychiatric disorders have been associated with alterations in the immune system linked to environmental exposures in early life, and since household pets are often among the first things with which children have close contact, it was logical for us to explore the possibilities of a connection between the two,” says Robert Yolken, M.D., chair of the Stanley Division of Pediatric Neurovirology and professor of neurovirology in pediatrics at the Johns Hopkins Children’s Center, and lead author of a research paper recently posted online in the journal PLOS One.

In the study, Yolken and colleagues at Sheppard Pratt Health System in Baltimore investigated the relationship between exposure to a household pet cat or dog during the first 12 years of life and a later diagnosis of schizophrenia or bipolar disorder. For schizophrenia, the researchers were surprised to see a statistically significant decrease in the risk of a person developing the disorder if exposed to a dog early in life. Across the entire age range studied, there was no significant link between dogs and bipolar disorder, or between cats and either psychiatric disorder.

The researchers caution that more studies are needed to confirm these findings, to search for the factors behind any strongly supported links, and to more precisely define the actual risks of developing psychiatric disorders from exposing infants and children under age 13 to pet cats and dogs.

According to the American Pet Products Association’s most recent National Pet Owners Survey, there are 94 million pet cats and 90 million pet dogs in the United States. Previous studies have identified early life exposures to pet cats and dogs as environmental factors that may alter the immune system through various means, including allergic responses, contact with zoonotic (animal) bacteria and viruses, changes in a home’s microbiome, and pet-induced stress reduction effects on human brain chemistry.

Some investigators, Yolken notes, suspect that this “immune modulation” may alter the risk of developing psychiatric disorders to which a person is genetically or otherwise predisposed.

In their current study, Yolken and colleagues looked at a population of 1,371 men and women between the ages of 18 and 65 that consisted of 396 people with schizophrenia, 381 with bipolar disorder and 594 controls. Information documented about each person included age, gender, race/ethnicity, place of birth and highest level of parental education (as a measure of socioeconomic status). Patients with schizophrenia and bipolar disorder were recruited from inpatient, day hospital and rehabilitation programs of Sheppard Pratt Health System. Control group members were recruited from the Baltimore area and were screened to rule out any current or past psychiatric disorders.

All study participants were asked if they had a household pet cat or dog or both during their first 12 years of life. Those who reported that a pet cat or dog was in their house when they were born were considered to be exposed to that animal since birth.

The relationship between the age of first household pet exposure and psychiatric diagnosis was defined using a statistical model that produces a hazard ratio — a measure over time of how often specific events (in this case, exposure to a household pet and development of a psychiatric disorder) happen in a study group compared to their frequency in a control group. A hazard ratio of 1 suggests no difference between groups, while a ratio greater than 1 indicates an increased likelihood of developing schizophrenia or bipolar disorder. Likewise, a ratio less than 1 shows a decreased chance.

Analyses were conducted for four age ranges: birth to 3, 4 to 5, 6 to 8 and 9 to 12.

Surprisingly, Yolken says, the findings suggests that people who are exposed to a pet dog before their 13th birthday are significantly less likely — as much as 24% — to be diagnosed later with schizophrenia.

“The largest apparent protective effect was found for children who had a household pet dog at birth or were first exposed after birth but before age 3,” he says.

Yolken adds that if it is assumed that the hazard ratio is an accurate reflection of relative risk, then some 840,000 cases of schizophrenia (24% of the 3.5 million people diagnosed with the disorder in the United States) might be prevented by pet dog exposure or other factors associated with pet dog exposure.

“There are several plausible explanations for this possible ‘protective’ effect from contact with dogs — perhaps something in the canine microbiome that gets passed to humans and bolsters the immune system against or subdues a genetic predisposition to schizophrenia,” Yolken says.

For bipolar disorder, the study results suggest there is no risk association, either positive or negative, with being around dogs as an infant or young child.

Overall for all ages examined, early exposure to pet cats was neutral as the study could not link felines with either an increased or decreased risk of developing schizophrenia or bipolar disorder.

“However, we did find a slightly increased risk of developing both disorders for those who were first in contact with cats between the ages of 9 and 12,” Yolken says. “This indicates that the time of exposure may be critical to whether or not it alters the risk.”

One example of a suspected pet-borne trigger for schizophrenia is the disease toxoplasmosis, a condition in which cats are the primary hosts of a parasite transmitted to humans via the animals’ feces. Pregnant women have been advised for years not to change cat litter boxes to eliminate the risk of the illness passing through the placenta to their fetuses and causing a miscarriage, stillbirth, or potentially, psychiatric disorders in a child born with the infection.

In a 2003 review paper, Yolken and colleague E. Fuller Torrey, M.D., associate director of research at the Stanley Medical Research Institute in Bethesda, Maryland, provided evidence from multiple epidemiological studies conducted since 1953 that showed there also is a statistical connection between a person exposed to the parasite that causes toxoplasmosis and an increased risk of developing schizophrenia. The researchers found that a large number of people in those studies who were diagnosed with serious psychiatric disorders, including schizophrenia, also had high levels of antibodies to the toxoplasmosis parasite.

Because of this finding and others like it, most research has focused on investigating a potential link between early exposure to cats and psychiatric disorder development. Yolken says the most recent study is among the first to consider contact with dogs as well.

“A better understanding of the mechanisms underlying the associations between pet exposure and psychiatric disorders would allow us to develop appropriate prevention and treatment strategies,” Yolken says.

Working with Yolken on the research team are the following members from Sheppard Pratt Health System: Cassie Stallings, Andrea Origoni, Emily Katsafanas, Kevin Sweeney, Amalia Squire, and Faith Dickerson, Ph.D., M.P.H.

The study was largely supported by grants from the Stanley Medical Research Institute

Story Source:

Materials provided by Johns Hopkins Medicine. Note: Content may be edited for style and length.